Humana (HUM) Revenue (2009 - 2026)

Humana (HUM) has reported Revenue for 18 consecutive years, with $40.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue rose 26.18% year-over-year to $40.9 billion in Q2 2026; TTM through Jun 2026 was $145.7 billion, a 18.33% increase from a year earlier, with the FY2025 full-year figure at $129.7 billion, up 10.11% from the prior year.
• Revenue was $40.9 billion for Q2 2026 at Humana, up from $39.6 billion in the prior quarter.
• Over five years, Revenue peaked at $40.9 billion in Q2 2026 and troughed at $654.0 million in Q4 2022.
• A 5-year average of $28.1 billion and a median of $29.3 billion in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue sank 96.89% in 2022 and jumped 3946.18% in 2023, its largest moves.
• Over 5 years, Revenue stood at $654.0 million in 2022, then jumped by 3946.18% to $26.5 billion in 2023, then grew by 10.4% to $29.2 billion in 2024, then increased by 11.3% to $32.5 billion in 2025, then increased by 25.69% to $40.9 billion in 2026.
• The last three Revenue figures came in at $40.9 billion (Q2 2026), $39.6 billion (Q1 2026), and $32.5 billion (Q4 2025), per Business Quant data.